Manufacturers Life Insurance Company, The Lyell Immunopharma, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 551,851 shares of LYEL stock, worth $391,814. This represents 0.0% of its overall portfolio holdings.
Number of Shares
551,851
Previous 552,556
0.13%
Holding current value
$391,814
Previous $762,000
53.67%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding LYEL
# of Institutions
108Shares Held
171MCall Options Held
7.7KPut Options Held
15.3K-
Mwg Management Ltd. Washington, DC20.2MShares$14.3 Million17.35% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$10.7 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$10.7 Million14.08% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$9.58 Million0.0% of portfolio
-
Decheng Capital LLC Menlo Park, CA11.9MShares$8.46 Million1.63% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $176M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...